Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177528 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00177528: Completed Phase 4 study, sponsored by University of Pittsburgh.
NCT00177528 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00177528, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
This research study is to evaluate the safety and usefulness of venlafaxine-XR in the treatment of major depression in the elderly.
Interventions
- DRUG venlafaxine-XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2000-10 |
| Phase | Phase 4 |
What the finished NCT00177528 record still lists
NCT00177528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which venlafaxine-XR is the first listed.
NCT00177528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00177528 about?
NCT00177528 is a clinical study titled "Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression". This research study is to evaluate the safety and usefulness of venlafaxine-XR in the treatment of major depression in the elderly.
What is the current status of trial NCT00177528?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2000-10.
What interventions are being tested in trial NCT00177528?
The interventions under investigation include: venlafaxine-XR (DRUG).
Who is sponsoring clinical trial NCT00177528?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00177528's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia